Publication | Closed Access

Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension

HypertensionCardiovascular DiseaseAntihypertensive AgentsShort-term Cardiovascular EffectsMedicinePhysiologyAntihypertensive TherapyCardiovascular PharmacologyVascular BiologyPharmacotherapyEssential HypertensionPharmacologyAtherosclerosisBlood Pressure